CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)
Clinical trial NCT03566043 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03566043
- Sponsor
- REGENXBIO Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2023-11-27
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.